Skip to main content
Earnings Labs
Dyadic International, Inc. logo

Dyadic International, Inc. (DYAI)

NASDAQ·Healthcare·Biotechnology

$1.11

+4.72%

Mkt Cap $28.95M

Analyst Ratings

No recent rating data.

Price Target (1 analysts)

$3.00

Range $3.00$3.00

Implied Upside

+170.3%

Consensus $3.00 vs current $1.11